文献速递消化、代谢与肾脏急症

静脉利多卡因/酮咯酸联合用药与单药治疗急诊疑似肾绞痛的比较

Comparison of intravenous lidocaine/ketorolac combination to either analgesic alone for suspected renal colic pain in the ED.
PubMed 文献 · Am J Emerg Med · 2019-01-30
一句话结论急诊疑似肾绞痛患者中,静脉利多卡因/酮咯酸联合用药的镇痛效果优于单用利多卡因,但相比单用酮咯酸无镇痛优势。

该随机双盲试验纳入150例18-64岁急诊疑似肾绞痛患者,比较静脉利多卡因(1.5 mg/kg)联合酮咯酸(30 mg)、单用酮咯酸(30 mg)及单用利多卡因(1.5 mg/kg)的镇痛效果与安全性。主要终点为30分钟时组间疼痛评分差异:利多卡因组与联合组差异为-2.89(95%CI:-4.39至-1.39);酮咯酸组与联合组差异为-0.92(95%CI:-2.44至0.61);酮咯酸组与利多卡因组差异为-1.98(95%CI:-3.69至-0.27)。各组30分钟和60分钟需补救镇痛的比例相当,未观察到生命体征的临床担忧变化,无严重不良事件,常见不良反应为头晕、恶心和头痛。结论提示联合用药相比单用利多卡因镇痛更优,但相比单用酮咯酸无额外镇痛获益。

要点

  • 30分钟疼痛评分:利多卡因组与联合组差异为-2.89(95%CI:-4.39至-1.39),联合组镇痛更优。
  • 30分钟疼痛评分:酮咯酸组与联合组差异为-0.92(95%CI:-2.44至0.61),未达统计学显著。
  • 30分钟疼痛评分:酮咯酸组与利多卡因组差异为-1.98(95%CI:-3.69至-0.27),酮咯酸组镇痛更优。
  • 各组30分钟和60分钟需补救镇痛的比例相当,无严重不良事件,常见不良反应为头晕、恶心和头痛。

适用人群与场景

  • 年龄18-64岁、就诊于急诊科、疑似肾绞痛的患者。

处置流程与药物剂量

  • 联合组:静脉利多卡因1.5 mg/kg联合酮咯酸30 mg。
  • 利多卡因组:静脉利多卡因1.5 mg/kg。
  • 酮咯酸组:静脉酮咯酸30 mg。

研究设计与关键结果

  • 随机双盲试验,纳入150例受试者(每组50例),比较静脉利多卡因(1.5 mg/kg)联合酮咯酸(30 mg)、单用酮咯酸(30 mg)及单用利多卡因(1.5 mg/kg)的镇痛效果与安全性。
  • 主要终点30分钟时平均疼痛评分差异:利多卡因组与联合组为-2.89(95%CI:-4.39至-1.39);酮咯酸组与联合组为-0.92(95%CI:-2.44至0.61);酮咯酸组与利多卡因组为-1.98(95%CI:-3.69至-0.27)。
  • 各组30分钟和60分钟需补救镇痛的比例相当。
  • 未观察到生命体征的临床担忧变化,无严重不良事件,常见不良反应为头晕、恶心和头痛。

证据类型、等级与局限

  • 证据类型:随机双盲试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急诊疑似肾绞痛患者,静脉利多卡因/酮咯酸联合用药相比单用利多卡因可提供更好的镇痛,但相比单用酮咯酸无镇痛优势(作者结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To compare analgesic efficacy and safety of intravenous lidocaine and ketorolac combination to each analgesic alone for ED patients with suspected renal colic.

METHODS: We conducted a randomized, double-blind trial comparing analgesic efficacy of a combination of intravenous lidocaine (1.5 mg/kg) and ketorolac (30 mg), to ketorolac (30 mg), and to lidocaine (1.5 mg/kg) in patients aged 18-64 presenting to the ED with suspected renal colic. Primary outcome included difference in pain scores between the groups at 30 min. Secondary outcomes included a comparative reduction in pain scores in each group from baseline to 30 and 60 min as well as rates of adverse events and need for rescue analgesia at 30 and 60 min.

RESULTS: We enrolled 150 subjects (50 per group). The difference in mean pain scores at 30 min between Lidocaine and Lidocaine/Ketorolac groups was -2.89 (95% CI: -4.39 to -1.39); between Ketorolac and Lidocaine/Ketorolac group was -0.92 (95% CI: -2.44 to 0.61); and between Ketorolac and Lidocaine was -1.98 (95% CI: -3.69 to -0.27). A comparative percentage of subjects in each group required rescue analgesia at 30 and 60 min. No clinically concerning changes in vital signs were observed. No serious adverse events occurred in either group. Commonly reported adverse effects were dizziness, nausea, and headache.

CONCLUSION: The administration of intravenous lidocaine/ketorolac combination to ED patients with suspected renal colic results in better analgesia in comparison to lidocaine alone but provides no analgesic advantages over ketorolac alone. Clinicaltrials.gov Registration: NCT02902770.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Motov S, Fassassi C, Drapkin J, et al. Comparison of intravenous lidocaine/ketorolac combination to either analgesic alone for suspected renal colic pain in the ED. Am J Emerg Med. 2019. PMID: 30770244. doi:10.1016/j.ajem.2019.01.048

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。